1. Home
  2. SNT vs GRML Comparison

SNT vs GRML Comparison

Compare SNT & GRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senstar Technologies Ltd.

SNT

Senstar Technologies Ltd.

SELL

Current Price

$1.43

Market Cap

35.9M

ML Signal

SELL

Logo Greenland Mines Ltd. Common Stock

GRML

Greenland Mines Ltd. Common Stock

SELL

Current Price

$6.38

Market Cap

29.2M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
SNT
GRML
Founded
1965
N/A
Country
Canada
United States
Employees
N/A
N/A
Industry
Telecommunications Equipment
Sector
Telecommunications
Exchange
Nasdaq
Nasdaq
Market Cap
35.9M
29.2M
IPO Year
2023
2022

Fundamental Metrics

Financial Performance
Metric
SNT
GRML
Price
$1.43
$6.38
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.9K
★ 18.0M
Earning Date
11-24-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 31.25
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$19.22
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.42
$0.16
52 Week High
$5.34
$18.21

Technical Indicators

Market Signals
Indicator
SNT
GRML
Relative Strength Index (RSI) 31.12 49.14
Support Level N/A $0.28
Resistance Level $1.67 $11.66
Average True Range (ATR) 0.08 1.55
MACD -0.01 -0.66
Stochastic Oscillator 0.00 12.21

Price Performance

Historical Comparison
SNT
GRML

About SNT Senstar Technologies Ltd.

Senstar Technologies Corp is an international provider of comprehensive physical, video, and access control security products and solutions. The company offers comprehensive solutions for critical sites, which leverage its broad portfolio of homegrown PIDS (Perimeter Intrusion Detection Systems), advanced VMS and SMS (Video Management Software and Security Management Software) with native IVA (Intelligent Video Analytics) security solutions, as well as access control products and technologies. Geographically, the company operates in North America, which derives maximum revenue; Europe; APAC; South and Latin America; and Others.

About GRML Greenland Mines Ltd. Common Stock

Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Share on Social Networks: